Study calls for cancer gene screenings for all Ashkenazi women

Israeli report insists that women of European extraction should be tested for BRCA mutation linked to breast cancer

A woman with breast cancer undergoing a CT scan, June 18, 2012. (photo credit: Chen Leopold/Flash90)
A woman with breast cancer undergoing a CT scan, June 18, 2012. (photo credit: Chen Leopold/Flash90)

All women of Ashkenazi descent should be screened from age 30 for the BRCA gene mutation that causes breast cancer, an Israeli study recommends.

The study, by a research team headed by Professor Ephrat Levy-Lahad of Shaare Zedek Medical Center, was published Friday in the journal Proceedings of the National Academy of Sciences of the United States of America.

Up until now, Ashkenazi women have been tested for the BRCA1 and BRCA2 genes only if a close blood relative developed breast or ovarian cancer or was identified as carrying the gene.

The research was conducted on a random group of Jewish women of Ashkenazi origin, who did not necessarily have a family history of the disease.

Many of the women identified during the study as being mutation carriers would not have known otherwise, according to the study. The mutation can be handed down to women through their fathers.

Most Popular
read more:
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.